Keywords: Watson, Allergan, Combigan, Patent challenge

Watson confirms US patent challenge to Allergan’s eye drug Combigan

Article | 08 September 2010

US generic drugs firm Watson Pharmaceuticals (NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories, filed an Abbreviated New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Allergan

Watson Pharmaceuticals

Go to company listing

Related Drugs

Combigan

Go to drug listing